Company CVAbout Venmax Drugs & Pharmaceuticals Ltd 
Venmax Drugs & Pharmaceuticals Ltd
Micro Cap
Pharmaceuticals & Drugs
Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Limited Company under the name and style of "Yenkay Medico Private Limited", on 28 September, 1998. The Company thereafter changed its name to "Yenkey Drugs & Pharmaceuticals Private Limited" on 18 January, 1995. It became a Public Limited Company on February 3, 1995 with "Yenkey Drugs & Pharmaceuticals Limited". Finally, the Company changed its name to "Venmax Drugs & Pharmaceuticals Limited" on April 13, 2009.
Company Coordinates
Company Details
H.No 1-140 Rajeswari Warehouse, Kompally Quthbullapur Hyderabad Telangana : 500014
Registrar Details
Cil Securities Ltd , 214 Raghava Ratna Towers , Chirag Ali Lane, Abidas, Hyderabad
Capital StructureCapital Structure
Present Equity Capital
INR 5.24 Cr
Number of Shares
52.39 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
12-May-2012
52.39
5.24
871280
10
BIFR
12-May-2012
52.39
5.24
871280
10
BIFR
31-Dec-2011
43.68
4.37
325000
10
Unspecified
31-Dec-2011
43.68
4.37
325000
10
Unspecified
30-Dec-2009
40.43
4.04
1400000
10
Conversion of Warrants
30-Dec-2009
40.43
4.04
1400000
10
Conversion of Warrants
31-Mar-2009
26.43
2.64
325000
10
Unspecified
31-Mar-2009
26.43
2.64
325000
10
Unspecified
29-Jan-2009
23.18
1.16
-2317650
5
Capital Reduction
29-Jan-2009
23.18
2.32
0
10
Consolidation of Shares
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Non Institution
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Venkat Narender Nuka (17.69%)
Highest Public shareholder
Percy Homi Italia (8.9%)
Individual Investors Holdings
65.54%
Board of Directors
Management
Designation
Remuneration
Rajkumar Rai
Managing Director
0
N Krishnaiah
Non Executive Director
5.0 k
A Ramakrishnaiah
Non Executive Independent Director
5.0 k
N V Narender
Chairman
0
Gali Satya Venkata Divya Jyothi
Non Executive Independent Director
5.0 k
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
Pharmaceuticals & Drugs
INR 15 Cr (Micro Cap)
15.00
33
0.00%
-0.24
-4.17%
-10.57
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
